Akèy › Skleroderm Difize › Michigan › Ann Arbor
Etid klinik pou Skleroderm Difize nan Ann Arbor, MI
7 etid pou Skleroderm Difize ap chèche patisipan nan sit nan ak bò kote Ann Arbor (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis
Ap rekriteFaz 2
- Uni Of Michigan Health System, Ann Arbor
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Ap rekriteFaz 2/3
- GSK Investigational Site, Ann Arbor
Platform Clinical Study for Conquering Scleroderma
Ap rekriteFaz 2
- University of Michigan, Ann Arbor
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
Ap rekriteFaz 2/3
- University of Michigan, Ann Arbor
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
Ap rekriteFaz 1/2
- Nkarta Investigational Site, Ann Arbor
A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis
Ap rekriteFaz 2
- Galderma Investigational Site # 8743, Ann Arbor
The Apollo Device in Systemic Sclerosis for the Management of fatiguE, Raynaud Phenomenon and qualiTy of Life
Ap rekrite
- University of Michigan, Ann Arbor
Etid Skleroderm Difize nan lòt vil
- New York City, NY8 etid
- Chicago, IL7 etid
- Los Angeles, CA6 etid
- Durham, NC6 etid
- Houston, TX5 etid
- Baltimore, MD5 etid
- Boston, MA5 etid
- Philadelphia, PA4 etid
- Kansas City, KS4 etid
- New Orleans, LA4 etid
- Pittsburgh, PA4 etid
- Charlotte, NC3 etid
Lòt etid nan Ann Arbor
- Kansè pwostat27 etid
- Kansè (tout kalite)26 etid
- Kansè nan tete26 etid
- Kansè Poumon ki pa ti selil26 etid
- Kansè poumon23 etid
- Kansè kolorektal23 etid
- Ensifizyans kadyak22 etid
- Leksemi mieloïd egi17 etid
- Maladi kadyovaskilè16 etid
- Kansè pankreyas14 etid
- Melanom12 etid
- Kansè renn (Kasinom selil renn)12 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.